Tower Research Capital LLC (Trc) Aeglea Bio Therapeutics, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.11 - $0.46 $1,609 - $6,730	-14,632 Reduced 39.14%	22,749 $10,000
Q1 2023 May 09, 2023	BUY	$0.29 - $0.61 $5,665 - $11,917	19,537 Added 109.49%	37,381 $11,000
Q4 2022 Feb 10, 2023	SELL	$0.35 - $1.54 $3,164 - $13,924	-9,042 Reduced 33.63%	17,844 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.38 - $0.81 $4,254 - $9,069	11,197 Added 71.37%	26,886 $14,000
Q2 2022 Aug 15, 2022	SELL	$0.5 - $2.66 $3,195 - $16,997	-6,390 Reduced 28.94%	15,689 $8,000
Q1 2022 May 12, 2022	BUY	$1.87 - $4.77 $32,027 - $81,695	17,127 Added 345.86%	22,079 $51,000
Q4 2021 Feb 14, 2022	BUY	$3.5 - $8.42 $5,957 - $14,330	1,702 Added 52.37%	4,952 $24,000
Q3 2021 Nov 15, 2021	BUY	$6.03 - $7.95 $1,380 - $1,820	229 Added 7.58%	3,250 $26,000
Q2 2021 Aug 16, 2021	BUY	$6.32 - $8.38 $2,351 - $3,117	372 Added 14.04%	3,021 $21,000
Q1 2021 May 17, 2021	SELL	$6.76 - $8.57 $39,566 - $50,160	-5,853 Reduced 68.84%	2,649 $21,000
Q4 2020 Feb 16, 2021	SELL	$7.02 - $9.83 $191,456 - $268,093	-27,273 Reduced 76.23%	8,502 $67,000
Q3 2020 Nov 16, 2020	BUY	$6.51 - $9.33 $163,850 - $234,826	25,169 Added 237.31%	35,775 $254,000
Q2 2020 Aug 13, 2020	BUY	$4.01 - $11.04 $42,530 - $117,090	10,606 New	10,606 $98,000
Q1 2020 May 15, 2020	SELL	$3.51 - $8.48 $25,665 - $62,005	-7,312 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$7.23 - $8.55 $42,584 - $50,359	5,890 Added 414.21%	7,312 $56,000
Q3 2019 Nov 05, 2019	BUY	$6.42 - $9.0 $9,129 - $12,798	1,422 New	1,422 $11,000
Q1 2019 May 14, 2019	SELL	$7.6 - $9.4 $17,654 - $21,836	-2,323 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$6.51 - $10.19 $14,165 - $22,173	2,176 Added 1480.27%	2,323 $17,000
Q3 2018 Nov 13, 2018	BUY	$8.24 - $11.0 $1,211 - $1,617	147 New	147 $1,000

Others Institutions Holding AGLE

# of Institutions

Shares Held

241K

Call Options Held

Put Options Held

Abingworth LLP London, X0

241K
Shares

$6.65 Million
0.04% of portfolio

View Full List

About Aeglea BioTherapeutics, Inc.

Ticker AGLE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,172,500
Market Cap $1.69B
Description
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy f...

More about AGLE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account